Brazil Market Potential - Biotech
October 8, 2015
The event which took place in the modern and beautiful HFN Conference Hall in Tel Aviv (with live videoconference feed to the Albert Einstein Hospital in Sao Paulo) was very well attended and demonstrated the outstanding innovation in Israeli Biotech.
A highly professional panel of Brazilian experts in Sao Paulo and Tel Aviv gave real-time commercial and clinical feedback to seven Israeli Healthcare companies. The panelists in Brazil included physicians and top managers from the Albert Einstein Hospital in SP specialized in the relevant medical fields who joined us through live teleconference. In Tel Aviv, the panel included Avi Meizler and Ronen Hausirer (bios below).
We heard some very interesting presentations ranging from Laboratory Diagnostics to Mobile Apps for Healthcare, and the Brazilian and Israeli panel members were all pleasantly surprised by the level of the presenters and presentations. The companies who presented were: Bio View, Night sense, Emerald Medical Applications, Ioptima, Carmel Diagnostics, Libra@Home and Navontech.
We were also lucky that so many private investors and representatives of venture funds attended the meeting in Israel to scout for potential technologies and products, which added to the networking value of the event.
As promised, the panel chose one company out of the 7 that they believe has a higher chance to succeed in Brazil both clinically and commercially. The panel chose Emerald Medical Applications and they will be accompanied by Atche Medical in their first steps into Brazil.
We are hopeful this becomes a bi-annual event with an opportunity for Israeli Biotech companies to receive valuable commercial input from the Brazilian market.
If you are interested in participating in the next event and/or if you have any questions about the Brazil Biotech Market – feel free to contact Atche Medical or the Israel-Brazil Chamber of Commerce!
*****************************************************************
We are pleased to invite you to our upcoming conference, Brazil Market Potential -
Biotech Event, on October 8th, 2015.
The event will feature a panel of Brazilian experts in Sao Paulo and Tel Aviv who will give real-time commercial and clinical feedback to a select number of companies. Each company selected to present, will give a short 8 minute pitch followed by 7 minutes of Q&A andfeedback from the panel.
*An additional company will be chosen to present via lottery at the event.*
The panelists include physicians from the Albert Einstein Hospital in SP, joining us through teleconference; Avi Meizler of Meizler UCB Biopharma S.A, Ronen Hausirer a partner in Herzog Fox & Neeman's Hi-Tech Department; and other investors and commercial representatives interested in supporting the efforts of Israeli companies entering the Brazilian Market.
At the end of the event, the panel will vote for the product “most likely to succeed in Brazil.” The winning team will receive free guidance from Atche Medical on how to advance their activity in Brazil.
Location:
Herzog Fox & Neeman
Asia House
4 Weizmann Street
Tel Aviv - ISRAEL
________________________________________________________________________________________
16:00-16:20 Registration and Networking
16:20-17:20 Pitches Round I + Q&A
Bio View | Night Sense | Emerald | Ioptima
17:20-17:30 Short Break
17:30-18:30 Pitches Round II + Q&A
Carmel Diagnostics | Libra@Home | Med Bright Medical Solutions
18:30-19:00 Closing Remarks
Mr. Avi Meizler
__________________________________________________________________________________
About the Panel:
Mr. Avi Meizler founded (1990) and was the President until June, 2012 of Meizler UCB Biopharma S.A. Mr. Meizler is Co-founded and CEO Advantech Bioscience Pharmaceutical Ltd, being responsible for the development of 02 biological components. Investor and Director of the board of Therapix Bioscience Ltd, Orimune Bio, Kadimastem Stem Cellss, Raziel Therapeutics, Nirolin lifescience. He has been an experienced businessman and entrepreneur in Brazil since 1979 in the fields of pharmaceuticals, engineering and construction.
Mr. Ronen Hausirer is a partner in the technology licensing group within the High-tech department at HFN. Specializing in commercial transactions between Israeli companies and major corporations in Asia, Europe and the U.S., Ronen advises clients from a range of industries including medical device, pharmaceuticals and bio-tech companies in a variety of transactions. Ronen specializes in technology licensing, technology transfer, general commercial transactions, joint ventures and strategic collaborations.
Albert Einstein Hospital in Brazil is the first Bone Marrow Transplantation Center in Latin America to receive FACT accreditation. HIAE is accredited for antilogous and allergenic transplantation. The hospital was founded in 1971 with the mission of providing quality health care, generating knowledge, and promoting social responsibility. In recent decades, an expansion plan doubled the hospital’s service area, expanded social programs of assistance to needy communities, and turned the hospital into a benchmark in organ transplants, in the public sector. HIAE works in close partnerships with governments for health assistance in various regions of São Paulo metropolis. The hospital’s research and educational institute has already trained approximately 130,000 professionals and conducts hundreds of studies annually.
Space is limited. Registration required.